Literature DB >> 23565131

Translational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk.

Rachel Nusbaum1, Kara-Grace Leventhal, Gillian W Hooker, Beth N Peshkin, Morgan Butrick, Yasmin Salehizadeh, William Tuong, Susan Eggly, Jeena Mathew, David Goerlitz, Peter G Shields, Marc D Schwartz, Kristi D Graves.   

Abstract

Although single nucleotide polymorphism (SNP) testing for disease susceptibility is commercially available, translational studies are necessary to understand how to communicate genomic information and potential implications for public health. We explored attitudes about and initial responses to genomic testing for colon cancer risk. Following development of the educational materials, we offered testing for three colon cancer SNPs in a pilot study with primary care patients. Participants completed pre- and post-test sessions and interviews. We analyzed interview transcripts with qualitative software using thematic analysis. All 20 participants opted for SNP testing. Qualitative analysis identified several themes: Motivations for SNP Testing, Before/After: Meaning of Results, Emotional Responses to SNP Results and Genomic Literacy/ Information Delivery. Results demonstrate that individuals will pursue SNP testing in the context of pre and post-test education. SNP results may influence health behaviors like healthy eating and exercise yet did not appear to impact colon cancer screening intentions.

Entities:  

Year:  2012        PMID: 23565131      PMCID: PMC3615724          DOI: 10.1007/s13142-012-0149-0

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  55 in total

1.  Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study.

Authors:  Saskia C Sanderson; Suzanne C O'Neill; Della Brown White; Gerold Bepler; Lori Bastian; Isaac M Lipkus; Colleen M McBride
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

2.  Considerations for the impact of personal genome information: a study of genomic profiling among genetics and genomics professionals.

Authors:  Julianne M O'Daniel; Susanne B Haga; Huntington F Willard
Journal:  J Genet Couns       Date:  2010-03-30       Impact factor: 2.537

Review 3.  Direct-to-consumer genomic testing: systematic review of the literature on user perspectives.

Authors:  Lesley Goldsmith; Leigh Jackson; Anita O'Connor; Heather Skirton
Journal:  Eur J Hum Genet       Date:  2012-02-15       Impact factor: 4.246

4.  "It's not like judgment day": public understanding of and reactions to personalized genomic risk information.

Authors:  Erynn S Gordon; Georgia Griffin; Lisa Wawak; Hauchie Pang; Sarah E Gollust; Barbara A Bernhardt
Journal:  J Genet Couns       Date:  2011-12-17       Impact factor: 2.537

Review 5.  Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics.

Authors:  J S Roberts; K D Christensen; R C Green
Journal:  Clin Genet       Date:  2011-07-18       Impact factor: 4.438

6.  Genetic risk estimation in the Coriell Personalized Medicine Collaborative.

Authors:  Catharine B Stack; Neda Gharani; Erynn S Gordon; Tara Schmidlen; Michael F Christman; Margaret A Keller
Journal:  Genet Med       Date:  2011-02       Impact factor: 8.822

7.  Perceived ambiguity about cancer prevention recommendations: associations with cancer-related perceptions and behaviours in a US population survey.

Authors:  Paul K J Han; Richard P Moser; William M P Klein
Journal:  Health Expect       Date:  2007-12       Impact factor: 3.377

8.  Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk.

Authors:  Emma Jaeger; Emily Webb; Kimberley Howarth; Luis Carvajal-Carmona; Andrew Rowan; Peter Broderick; Axel Walther; Sarah Spain; Alan Pittman; Zoe Kemp; Kate Sullivan; Karl Heinimann; Steven Lubbe; Enric Domingo; Ella Barclay; Lynn Martin; Maggie Gorman; Ian Chandler; Jayaram Vijayakrishnan; Wendy Wood; Elli Papaemmanuil; Steven Penegar; Mobshra Qureshi; Susan Farrington; Albert Tenesa; Jean-Baptiste Cazier; David Kerr; Richard Gray; Julian Peto; Malcolm Dunlop; Harry Campbell; Huw Thomas; Richard Houlston; Ian Tomlinson
Journal:  Nat Genet       Date:  2007-12-16       Impact factor: 38.330

9.  Patients' understanding of and responses to multiplex genetic susceptibility test results.

Authors:  Kimberly A Kaphingst; Colleen M McBride; Christopher Wade; Sharon Hensley Alford; Robert Reid; Eric Larson; Andreas D Baxevanis; Lawrence C Brody
Journal:  Genet Med       Date:  2012-07       Impact factor: 8.822

Review 10.  Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.

Authors:  Theresa M Marteau; David P French; Simon J Griffin; A T Prevost; Stephen Sutton; Clare Watkinson; Sophie Attwood; Gareth J Hollands
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06
View more
  11 in total

1.  Discussing race-related limitations of genomic testing for colon cancer risk: implications for education and counseling.

Authors:  Morgan N Butrick; Lauren Vanhusen; Kara-Grace Leventhal; Gillian W Hooker; Rachel Nusbaum; Beth N Peshkin; Yasmin Salehizadeh; Jessica Pavlick; Marc D Schwartz; Kristi D Graves
Journal:  Soc Sci Med       Date:  2014-05-15       Impact factor: 4.634

2.  Barriers and Facilitators for Population Genetic Screening in Healthy Populations: A Systematic Review.

Authors:  Emily C Shen; Swetha Srinivasan; Lauren E Passero; Caitlin G Allen; Madison Dixon; Kimberly Foss; Brianna Halliburton; Laura V Milko; Amelia K Smit; Rebecca Carlson; Megan C Roberts
Journal:  Front Genet       Date:  2022-07-04       Impact factor: 4.772

3.  Behavioral and psychosocial responses to genomic testing for colorectal cancer risk.

Authors:  Kristi D Graves; Kara-Grace Leventhal; Rachel Nusbaum; Yasmin Salehizadeh; Gillian W Hooker; Beth N Peshkin; Morgan Butrick; William Tuong; Jeena Mathew; David Goerlitz; Mary B Fishman; Peter G Shields; Marc D Schwartz
Journal:  Genomics       Date:  2013-04-11       Impact factor: 5.736

Review 4.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

5.  Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review.

Authors:  Tatiane Yanes; Amanda M Willis; Bettina Meiser; Katherine M Tucker; Megan Best
Journal:  Eur J Hum Genet       Date:  2018-09-11       Impact factor: 4.246

6.  The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families.

Authors:  Beth N Peshkin; Mary Kate Ladd; Claudine Isaacs; Hannah Segal; Aryana Jacobs; Kathryn L Taylor; Kristi D Graves; Suzanne C O'Neill; Marc D Schwartz
Journal:  J Cancer Educ       Date:  2021-02       Impact factor: 2.037

7.  Incorporation of personal single nucleotide polymorphism (SNP) data into a national level electronic health record for disease risk assessment, part 3: an evaluation of SNP incorporated national health information system of Turkey for prostate cancer.

Authors:  Timur Beyan; Yeşim Aydın Son
Journal:  JMIR Med Inform       Date:  2014-08-19

8.  Incorporation of personal single nucleotide polymorphism (SNP) data into a national level electronic health record for disease risk assessment, part 1: an overview of requirements.

Authors:  Timur Beyan; Yeşim Aydın Son
Journal:  JMIR Med Inform       Date:  2014-07-24

Review 9.  Internet-Based Direct-to-Consumer Genetic Testing: A Systematic Review.

Authors:  Loredana Covolo; Sara Rubinelli; Elisabetta Ceretti; Umberto Gelatti
Journal:  J Med Internet Res       Date:  2015-12-14       Impact factor: 5.428

10.  Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study.

Authors:  Tatiane Yanes; Bettina Meiser; Mary-Anne Young; Rajneesh Kaur; Gillian Mitchell; Kristine Barlow-Stewart; Tony Roscioli; Jane Halliday; Paul James
Journal:  BMC Cancer       Date:  2017-07-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.